TAG:
new diagnostic technology
New Lab Management Directions Now Visible
By Robert Michel | From the Volume X No. 7 – May 27, 2003 Issue
CEO SUMMARY: Seat-of-the-pants laboratory management is on its way out, replaced by numbers-driven methods. Judging by the presentations given at this year’s Executive War College on Lab and Pathology Management, a growing number of laboratory administrators and pathologists are activel…
New Trends in 2003 Affect Clinical Lab Services
By Robert Michel | From the Volume X No. 1 – January 20, 2003 Issue
CEO SUMMARY: Here’s our current list of macro trends that affect clinical laboratories, updated from the last list in January 2000. One bold prediction is that Medicare, as we know it, is on the verge of a major meltdown. Employers and consumers are also new forces to be reckoned with b…
ARUP & Mayo Respond To New Market Cycle
By Robert Michel | From the Volume IX No. 14 – October 7, 2002 Issue
CEO SUMMARY: Since the beginning of 2002, several important events changed the competitive status quo among the nation’s leading providers of hospital send-out testing. As part of its ongoing assessment of this market segment, THE DARK REPORT provides strategic management insights from …
Lab Testing to Boom During This Decade
By Robert Michel | From the Volume IX No. 11 – August 5, 2002 Issue
CEO SUMMARY: Several recent acquisitions of lab test technology by billion-dollar diagnostics manufacturers reinforce a new reality in the healthcare marketplace: developing new diagnostic tests is faster, cheaper, and more profitable than developing new pharmaceutical products. This simp…
Big Fight is Brewing Over Lab Test Reimbursement
By R. Lewis Dark | From the Volume IX No. 8 – June 3, 2002 Issue
BY NOW, MOST LAB EXECUTIVES AND PATHOLOGISTS AGREE that Medicare Part B fees and reimbursement guidelines for lab testing have just about become de facto national standards. That’s because private payers increasingly use Medicare as the basis for building their own pricing and reimbursement guideli…
Ken Freeman Discusses Plans to Integrate AML and Unilab
By Robert Michel | From the Volume IX No. 6 – April 22, 2002 Issue
CEO SUMMARY: Once again, Ken Freeman and Quest Diagnostics Incorporated is altering the national market for clinical laboratory testing. By acquiring American Medical Laboratories and Unilab, the nation’s largest lab company is expanding its presence in California, Nevada, and Washingto…
American Healthcare At a New Crossroads
By R. Lewis Dark | From the Volume VIII No. 17 – December 17, 2001 Issue
IN SELECTING OUR “TOP TEN” BIGGEST STORIES of the lab industry for 2001, we’ve had some interesting discussions here at THE DARK REPORT about what’s happening in the American healthcare system and how it’s affecting laboratories and pathology group practices. I believe that our healthcare…
Year’s Ten Biggest Stories Reveal Modest Changes
By Robert Michel | From the Volume VII No. 17 – December 4, 2000 Issue
CEO SUMMARY: In many ways, 2000 was a relatively quiet year for laboratory organizations. This list of the ten biggest stories in the lab industry for 2000 demonstrates that the most innovative laboratory organizations in the United States are “raising the bar” for service and quality…
Prognostic versus Diagnostic Lab Medicine
By R. Lewis Dark | From the Volume VII No. 16 – November 13, 2000 Issue
MOST OF YOU ARE FAMILIAR WITH THE RACE TO DEVELOP effective laboratory tests and pharmaceuticals based on rapidly-developing genetic and molecular knowledge. We all ask the same question: when will my laboratory have to buy this technology and offer these new tests? For most of us, the answer is “…
Bill Bonello Sees Opportunities In Diagnostic Services Companies
By Robert Michel | From the Volume VII No. 14 – October 2, 2000 Issue
CEO SUMMARY: With the clinical laboratory industry now enjoying growing interest by professional investors, THE DARK REPORT traveled to New York City to meet with financial analyst William B. Bonello, of U S Bancorp Piper Jaffray. Bonello co-authored a just-released overview of what he ca…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized